Round Type
Private Equity
San AntonioBiotechnologyHealth CareTherapeuticsPharmaceuticalConsultingBiopharmaDescription
LumaBridge (formerly known as Cancer Insight), an oncology-focused clinical research organization (CRO), today announced a majority growth investment from global investor Summit Partners. The funding will help LumaBridge continue to build on its work offering best-in-class clinical trial solutions to support emerging biopharma companies that are working to develop life-changing immuno-oncology treatments.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as LumaBridge that raised within 45 days of this round, from Fundz verified event records.
- Abivax raised $49M (Funding Round) on September 2, 2022.
- CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
- SpringWorks raised $225M (Post-IPO Equity) on September 7, 2022.
- Pharnext raised an undisclosed amount (Debt Financing) on October 3, 2022.
- Damona Pharmaceuticals raised $5.5M (Seed) on September 28, 2022.
- Qnovia raised $17M (Series A) on September 28, 2022.
Who to call at LumaBridge, and when
A new round usually means LumaBridge is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LumaBridge raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LumaBridge, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LumaBridge. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LumaBridge raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
LumaBridge raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.